TCL Archive NCAB, Panel May Look A Discrepancies, In Study Section Evaluation Of Grant Applications September 4, 1981
TCL Archive Minority Accrual Low In Prevention Trials; NCI Plans Programs To Boost enrollment February 2, 1996
TCL Archive Decisively Positive Swedish Study of PSA Becomes Focus of Debate Over Screening October 28, 2011
TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
